FDA approves Theravance's lung drug for wider use

(Reuters) - The U.S. Food and Drug Administration approved Theravance Inc's antibiotic lung drug to treat a type of bacterial pneumonia affecting hospitalized patients, particularly those on ventilators.

http://feedproxy.google.com/~r/reuters/healthNews/~3/8iVacdIiYik/story01.htm

Source: Reuters: Health - June 21, 2013 Category: Consumer Health News Tags: healthNews Source Type: news

More News: Bacterial Pneumonia | Food and Drug Administration (FDA) | Health | Pneumonia